Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Kavanagh

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Bladder Cancer (Amsterdam, Netherlands)|August 22, 2017
The Antineoplastic Activity of Photothermal Ablative Therapy with Targeted Gold Nanorods in an Orthotopic Urinary Bladder Cancer ModelXiaoping Yang, Lih-Jen Su, Francisco G La Rosa, et al.
Journal of Applied Clinical Medical Physics|April 25, 2017
A complete 4DCT-ventilation functional avoidance virtual trial: Developing strategies for prospective clinical trialsTimothy Waxweiler, Leah Schubert, Quentin Diot, et al.
Practical Radiation Oncology|September 18, 2016
Early and multiple PSA bounces can occur following high-dose prostate stereotactic body radiation therapy: Subset analysis of a phase 1/2 trialD Nathan Kim, Christopher Straka, L Chinsoo Cho, et al.
Cancer Research|January 17, 2009
Potentiating endogenous antitumor immunity to prostate cancer through combination immunotherapy with CTLA4 blockade and GM-CSFLawrence Fong, Serena S Kwek, Shaun O'Brien, et al.
Cancer Treatment and Research Communications|March 11, 2019
Phase II study of stereotactic radiosurgery for the treatment of patients with oligoprogression on erlotinibJared Weiss, Brian Kavanagh, Allison Deal, et al.
International Journal of Radiation Oncology, Biology, Physics|February 2, 2010
American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapyLouis Potters, Brian Kavanagh, James M Galvin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 2, 2019
Natural History and Factors Associated with Overall Survival in Stage IV ALK-Rearranged Non-Small Cell Lung CancerJose M Pacheco, Dexiang Gao, Derek Smith, et al.
Advances in Radiation Oncology|January 9, 2023
Characterizing Pulmonary Function Test Changes for Patients With Lung Cancer Treated on a 2-Institution, 4-Dimensional Computed Tomography-Ventilation Functional Avoidance Prospective Clinical TrialRyan Miller, Richard Castillo, Edward Castillo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 29, 2023
Evaluation of variables predicting PFT changes for lung cancer patients treated on a prospective 4DCT-ventilation functional avoidance clinical trialNader Ghassemi, Richard Castillo, Edward Castillo, et al.
International Journal of Radiation Oncology, Biology, Physics|January 28, 2020
Evaluating Positron Emission Tomography-Based Functional Imaging Changes in the Heart After Chemo-Radiation for Patients With Lung CancerYevgeniy Vinogradskiy, Quentin Diot, Bernard Jones, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Bladder Cancer (Amsterdam, Netherlands)|August 22, 2017
The Antineoplastic Activity of Photothermal Ablative Therapy with Targeted Gold Nanorods in an Orthotopic Urinary Bladder Cancer ModelXiaoping Yang, Lih-Jen Su, Francisco G La Rosa, et al.
Journal of Applied Clinical Medical Physics|April 25, 2017
A complete 4DCT-ventilation functional avoidance virtual trial: Developing strategies for prospective clinical trialsTimothy Waxweiler, Leah Schubert, Quentin Diot, et al.
Practical Radiation Oncology|September 18, 2016
Early and multiple PSA bounces can occur following high-dose prostate stereotactic body radiation therapy: Subset analysis of a phase 1/2 trialD Nathan Kim, Christopher Straka, L Chinsoo Cho, et al.
Cancer Research|January 17, 2009
Potentiating endogenous antitumor immunity to prostate cancer through combination immunotherapy with CTLA4 blockade and GM-CSFLawrence Fong, Serena S Kwek, Shaun O'Brien, et al.
Cancer Treatment and Research Communications|March 11, 2019
Phase II study of stereotactic radiosurgery for the treatment of patients with oligoprogression on erlotinibJared Weiss, Brian Kavanagh, Allison Deal, et al.
International Journal of Radiation Oncology, Biology, Physics|February 2, 2010
American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapyLouis Potters, Brian Kavanagh, James M Galvin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 2, 2019
Natural History and Factors Associated with Overall Survival in Stage IV ALK-Rearranged Non-Small Cell Lung CancerJose M Pacheco, Dexiang Gao, Derek Smith, et al.
Advances in Radiation Oncology|January 9, 2023
Characterizing Pulmonary Function Test Changes for Patients With Lung Cancer Treated on a 2-Institution, 4-Dimensional Computed Tomography-Ventilation Functional Avoidance Prospective Clinical TrialRyan Miller, Richard Castillo, Edward Castillo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 29, 2023
Evaluation of variables predicting PFT changes for lung cancer patients treated on a prospective 4DCT-ventilation functional avoidance clinical trialNader Ghassemi, Richard Castillo, Edward Castillo, et al.
International Journal of Radiation Oncology, Biology, Physics|January 28, 2020
Evaluating Positron Emission Tomography-Based Functional Imaging Changes in the Heart After Chemo-Radiation for Patients With Lung CancerYevgeniy Vinogradskiy, Quentin Diot, Bernard Jones, et al.
Pageof 10